These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26087886)

  • 1. miR-15b is Downregulated in Myasthenia Gravis Patients and Directly Regulates the Expression of Interleukin-15 (IL-15) in Experimental Myasthenia Gravis Mice.
    Shi L; Liu T; Zhang M; Guo Y; Song C; Song D; Liu H
    Med Sci Monit; 2015 Jun; 21():1774-80. PubMed ID: 26087886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel MicroRNA signatures linked to experimental autoimmune myasthenia gravis pathogenesis: down-regulated miR-145 promotes pathogenetic Th17 cell response.
    Wang J; Zheng S; Xin N; Dou C; Fu L; Zhang X; Chen J; Zhang Y; Geng D; Xiao C; Cui G; Shen X; Lu Y; Wang J; Dong R; Qiao Y; Zhang Y
    J Neuroimmune Pharmacol; 2013 Dec; 8(5):1287-302. PubMed ID: 24043548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered expression of miR-125a-5p in thymoma-associated myasthenia gravis and its down-regulation of foxp3 expression in Jurkat cells.
    Li J; Qiu D; Chen Z; Du W; Liu J; Mo X
    Immunol Lett; 2016 Apr; 172():47-55. PubMed ID: 26875774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of miR-29 family associated with autoimmune myasthenia gravis.
    Cron MA; Payet CA; Fayet OM; Maillard S; Truffault F; Fadel E; Guihaire J; Berrih-Aknin S; Liston A; Le Panse R
    J Neuroinflammation; 2020 Oct; 17(1):294. PubMed ID: 33032631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression of miR-146a in myasthenia gravis.
    Lu J; Yan M; Wang Y; Zhang J; Yang H; Tian FF; Zhou W; Zhang N; Li J
    Neurosci Lett; 2013 Oct; 555():85-90. PubMed ID: 24036458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease specific signature of circulating miR-150-5p and miR-21-5p in myasthenia gravis patients.
    Punga AR; Andersson M; Alimohammadi M; Punga T
    J Neurol Sci; 2015 Sep; 356(1-2):90-6. PubMed ID: 26095457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum interleukin 15 levels in patients with seropositive myasthenia gravis do not correlate with disease severity.
    Sobieszczuk E; Kubiszewska J; Lipowska M; Szczudlik P; Szyluk B; Dutkiewicz M; Kostera-Pruszczyk A
    Neurol Neurochir Pol; 2018; 52(3):364-367. PubMed ID: 29699793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-15b Suppresses Th17 Differentiation and Is Associated with Pathogenesis of Multiple Sclerosis by Targeting
    Liu R; Ma X; Chen L; Yang Y; Zeng Y; Gao J; Jiang W; Zhang F; Li D; Han B; Han R; Qiu R; Huang W; Wang Y; Hao J
    J Immunol; 2017 Apr; 198(7):2626-2639. PubMed ID: 28228555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablation of IL-17 expression moderates experimental autoimmune myasthenia gravis disease severity.
    Aguilo-Seara G; Xie Y; Sheehan J; Kusner LL; Kaminski HJ
    Cytokine; 2017 Aug; 96():279-285. PubMed ID: 28599246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-20b Inhibits T Cell Proliferation and Activation via NFAT Signaling Pathway in Thymoma-Associated Myasthenia Gravis.
    Xin Y; Cai H; Lu T; Zhang Y; Yang Y; Cui Y
    Biomed Res Int; 2016; 2016():9595718. PubMed ID: 27833920
    [No Abstract]   [Full Text] [Related]  

  • 11. Altered let-7 expression in Myasthenia gravis and let-7c mediated regulation of IL-10 by directly targeting IL-10 in Jurkat cells.
    Jiang L; Cheng Z; Qiu S; Que Z; Bao W; Jiang C; Zou F; Liu P; Liu J
    Int Immunopharmacol; 2012 Oct; 14(2):217-23. PubMed ID: 22835429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease-specific signature of serum miR-20b and its targets IL-8 and IL-25, in myasthenia gravis patients.
    Chunjie N; Huijuan N; Zhao Y; Jianzhao W; Xiaojian Z
    Eur Cytokine Netw; 2015 Sep; 26(3):61-6. PubMed ID: 26845056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine receptor expression in a rat model of experimental autoimmune myasthenia gravis.
    Li N; Wang G; Yao X; Kong Q; Shang X; Xie X; Wang J; Kang X; Jin L; Wang G; Li H; Mu L; Sun B
    Cell Immunol; 2014 Aug; 290(2):217-25. PubMed ID: 25086239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased microRNA miR-181c expression in peripheral blood mononuclear cells correlates with elevated serum levels of IL-7 and IL-17 in patients with myasthenia gravis.
    Zhang Y; Guo M; Xin N; Shao Z; Zhang X; Zhang Y; Chen J; Zheng S; Fu L; Wang Y; Zhou D; Chen H; Huang Y; Dong R; Xiao C; Liu Y; Geng D
    Clin Exp Med; 2016 Aug; 16(3):413-21. PubMed ID: 25962782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis.
    Tüzün E; Saini SS; Ghosh S; Rowin J; Meriggioli MN; Christadoss P
    Neuromuscul Disord; 2006 Feb; 16(2):137-43. PubMed ID: 16427283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The limitation of IL-10-exposed dendritic cells in the treatment of experimental autoimmune myasthenia gravis and myasthenia gravis.
    Xiao BG; Duan RS; Zhu WH; Lu CZ
    Cell Immunol; 2006 Jun; 241(2):95-101. PubMed ID: 17005165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing miR-146a influences B cells and ameliorates experimental autoimmune myasthenia gravis.
    Zhang J; Jia G; Liu Q; Hu J; Yan M; Yang B; Yang H; Zhou W; Li J
    Immunology; 2015 Jan; 144(1):56-67. PubMed ID: 24962817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-548k regulates CXCL13 expression in myasthenia gravis patients with thymic hyperplasia and in Jurkat cells.
    Li J; Qiu D; Chen Z; Du W; Liu J; Mo X
    J Neuroimmunol; 2018 Jul; 320():125-132. PubMed ID: 29661539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis.
    Aricha R; Mizrachi K; Fuchs S; Souroujon MC
    J Autoimmun; 2011 Mar; 36(2):135-41. PubMed ID: 21193288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-1933-3p is upregulated in skeletal muscles of MuSK+ EAMG mice and affects Impa1 and Mrpl27.
    Bogatikov E; Lindblad I; Punga T; Punga AR
    Neurosci Res; 2020 Feb; 151():46-52. PubMed ID: 30763589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.